The Stigma and Systemic Barriers Against Lifesaving Opioid Addiction Treatments in the U.S.

The opioid overdose epidemic has been devastating the U.S. for nearly three decades despite the availability of effective treatments like methadone and buprenorphine. These medications, which significantly reduce the risk of overdose and death, are underutilized due to widespread stigma and systemic barriers. A yearlong investigation by STAT reveals a conscious societal choice to obstruct these treatments, contributing to tens of thousands of preventable deaths annually. Barriers range from Narcotics Anonymous’ opposition and pharmacies refusing to stock medications to restrictive federal regulations and lack of access in jails and prisons. Additionally, private equity’s involvement in methadone clinics and myths about the medications exacerbate the problem. Despite evidence proving their effectiveness, a significant portion of Americans with opioid use disorder remain untreated, highlighting a grim picture of neglect and misunderstanding surrounding addiction treatment in the U.S.

To read more, click here.

[Source: STAT, March 5th, 2024]